Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazol
2. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
3. Nasea
4. Ramosetron
5. Ym 060
6. Ym-060
7. Ym060
1. 132907-72-3
2. Ramosetron Hcl
3. Nasea
4. Irribow
5. Ym060
6. Ym-060
7. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-6-yl)methanone Hydrochloride
8. Ym 060
9. Ramosetron.hcl
10. Ramosetron (hydrochloride)
11. (r)-(-)-ramosetron Hydrochloride
12. 9551lhd87e
13. Dsstox_cid_1223
14. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone;hydrochloride
15. (r)-5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazole Hydrochloride
16. Dsstox_rid_76021
17. Dsstox_gsid_21223
18. Ramosetron Hydrochloride (jan)
19. Ramosetron Hydrochloride [jan]
20. Ccris 7704
21. Cas-132907-72-3
22. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-
23. Unii-9551lhd87e
24. (r)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1h-benzimidazole Hydrochloride
25. Nasea Od
26. (-)-(r)-5-((1-methyl-1h-indol-3-yl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazole Monohydrochloride
27. (-)-(r)-5-[(1-methyl-1h-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1h-benzimidazole Monohydrochloride
28. Methanone, (1-methyl-1h-indol-3-yl)((6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl)-, Hydrochloride (1:1)
29. Methanone, (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]-, Hydrochloride (1:1)
30. Irribow (tn)
31. Nasea (tn)
32. Ramosetron Hydrochloride,(s)
33. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
34. Schembl447023
35. Chembl3181841
36. Dtxsid3021223
37. Chebi:32088
38. Act02590
39. Amy15420
40. Hy-b0595
41. Ym060ym-060
42. Tox21_112441
43. Mfcd19441800
44. Ramosetron Hydrochloride [mi]
45. S3723
46. Akos015895434
47. Tox21_112441_1
48. Ccg-267653
49. Ks-1311
50. Ramosetron Hydrochloride [mart.]
51. Ncgc00167437-02
52. Ramosetron Hydrochloride [who-dd]
53. (1-methyl-1h-indol-3-yl)[(5r)-4,5,6,7-tetrahydro-1h-benzimidazol-5-yl]methanone Hydrochloride
54. (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]methanone Hydrochloride
55. Methanone, (1-methyl-1h-indol-3-yl)((5r)-4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride
56. R-145
57. D02016
58. 907r723
59. A806524
60. Q27271742
61. (r)-(-)-5-[(1-methylindol-3-yl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole Hydrochloride
62. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone;hydrochloride.
63. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-5-yl)methanone Hydrochloride
Molecular Weight | 315.8 g/mol |
---|---|
Molecular Formula | C17H18ClN3O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 315.1138399 g/mol |
Monoisotopic Mass | 315.1138399 g/mol |
Topological Polar Surface Area | 50.7 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 413 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?